| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| KALA BIO, Inc. | CHIEF BUSINESS OFFICER | Common Stock | 59.7K | $284K | $4.75 | Jun 26, 2024 | Direct |
| KALA BIO, Inc. | CHIEF BUSINESS OFFICER | Stock Option (right to buy) | 20.5K | Jan 4, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| KALA | KALA BIO, Inc. | Jun 26, 2024 | 1 | -$24.5K | 4 | Jun 27, 2024 | CHIEF BUSINESS OFFICER |
| KALA | KALA BIO, Inc. | May 31, 2024 | 1 | -$1.41K | 4 | Jun 3, 2024 | CHIEF BUSINESS OFFICER |
| KALA | KALA BIO, Inc. | Jan 4, 2024 | 3 | -$9.32K | 4 | Jan 5, 2024 | CHIEF BUSINESS OFFICER |
| KALA | Kala Pharmaceuticals, Inc. | Jun 22, 2023 | 2 | $0 | 4 | Jun 23, 2023 | CHIEF BUSINESS OFFICER |
| KALA | Kala Pharmaceuticals, Inc. | Mar 14, 2023 | 1 | $0 | 4 | Mar 15, 2023 | CHIEF BUSINESS OFFICER |
| KALA | Kala Pharmaceuticals, Inc. | Feb 15, 2023 | 5 | $0 | 4 | Jun 2, 2023 | CHIEF BUSINESS OFFICER |
| KALA | Kala Pharmaceuticals, Inc. | Jan 4, 2023 | 1 | $0 | 4 | Jan 6, 2023 | CHIEF BUSINESS OFFICER |
| KALA | Kala Pharmaceuticals, Inc. | Nov 15, 2021 | 2 | $0 | 4 | Nov 17, 2021 | CHIEF BUSINESS OFFICER |
| KALA | Kala Pharmaceuticals, Inc. | Nov 15, 2021 | 0 | $0 | 3 | Nov 17, 2021 | CHIEF BUSINESS OFFICER |